Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) — The “Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Product Manufactured, Type of API, API Potency, Type of FDF, Dosage Form, Type of Packaging Offered, Scale of Operation, End Users and Key Geographical Regions ” has been added to ResearchAndMarkets.com’s offering.
The global pharmaceutical contract manufacturing market is set to expand significantly, projected to escalate from USD 99 billion in 2025 to USD 156 billion by 2035, growing at a CAGR of 4.3%.
This growth is driven by a rising demand for streamlined product delivery processes and the increasing complexity of pharmaceutical production. By leveraging CMOs and CDMOs, companies can mitigate risks related to economic and political uncertainty, diversifying their manufacturing operations worldwide. Technological advancements, such as automation and data analytics, are enhancing efficiency and quality in manufacturing.
Contract manufacturers in the pharmaceutical sector play a crucial role in meeting complex regulatory demands, optimizing production, and bridging clinical and commercial manufacturing. This presents promising opportunities for contract service providers throughout the forecast period.
Currently, approximately 425 organizations provide pharmaceutical contract manufacturing services, most of which offer fill-finish, packaging, and labeling services. The FDF segment dominates, with about 15% of these companies equipped to manufacture all finished dosage forms. Companies are enhancing their small molecule manufacturing capabilities through mergers and acquisitions to establish a competitive edge.
To accommodate the rising demand for APIs and finished products, especially in the US and India, CMOs are expanding capabilities aggressively. Large players dominate, controlling 80% of the total global manufacturing capacity. Increased outsourcing of small molecule manufacturing will significantly boost the market. There’s a shift towards developing regions in Asia-Pacific, impacting market landscapes positively through stakeholder expansions and mergers. Notably, North America is expected to claim over 35% of the market share by 2035.
Segmentation in the report covers various product types and operational scales. The FDF segment leads due to the demand for ready-to-make products and strict regulations, while generic and originator APIs share the market equally. High potent APIs are set for rapid growth due to their efficacy. Originator FDFs hold the largest market share based on brand loyalty and R&D investments, while liquid dosage forms will grow fastest, driven by ease of use.
Bottles are the most popular packaging option due to their cost-effectiveness and adaptability. Commercial scale manufacturing predominates, though clinical scale’s CAGR is rising. Small companies dominate the market, with substantial growth expected from mid-sized firms by 2035.
Profiling key industry players like AMRI Global, Catalent, and WuXi AppTec, the report emphasizes the importance of mergers, acquisitions, and strategic expansions. Regulatory landscapes and market dynamics are thoroughly analyzed, providing stakeholders vital insights into current trends and future opportunities in this rapidly-evolving market.
Investors and firms can leverage this detailed analysis to navigate the competitive market, formulate strategic plans, and make informed decisions. The report is pivotal for understanding market structures, with comprehensive data on production capacities, industry dynamics, and geographical growth trends.
Key Topics Covered:
1. Preface
2. Research Methodology
3. Economic And Other Project Specific Considerations
4. Executive Summary
5. Introduction
6. Pharmaceutical Cmos: Regulatory Landscape
7. Pharmaceutical Cmos: Market Landscape
8. Regional Capability
9. Company Profiles
10. Short Profiles
11. Make Versus Buy Decision Framework
12. Mergers And Acquisitions
13. Recent Expansions
14. Capacity Analysis
15. Demand Analysis
16. Market Impact Analysis: Drivers, Restraints, Opportunities And Challenges
17. Global Pharmaceutical Contract Manufacturing Market
18. Pharmaceutical Contract Manufacturing Market, By Type Of Product Manufactured
19. Pharmaceutical Api Contract Manufacturing Market, By Type Of Api
20. Pharmaceutical Api Contract Manufacturing Market, By Api Potency
21. Pharmaceutical Fdf Contract Manufacturing Market, By Type Of Fdf
22. Pharmaceutical Fdf Contract Manufacturing Market, By Dosage Form
23. Pharmaceutical Contract Manufacturing Market, By Type Of Packaging Offered
24. Pharmaceutical Contract Manufacturing Market, By End-Users
25. Pharmaceutical Contract Manufacturing Market, By Scale Of Operation
26. Pharmaceutical Contract Manufacturing Market, By Key Geographical Regions
27. Pharmaceutical Contract Manufacturing Market, By Leading Players
28. Case Study: Comparison Of Small And Large Molecules Drugs / Therapies
29. Concluding Remarks
30. Executive Insights
31. Appendix I: Tabulated Data
32. Appendix II: List Of Companies And Organizations
- AMRI Global
- Altasciences
- Cambrex
- Catalent
- DPT Laboratories
- Aenova
- Almac
- Corden Pharma
- Fresenius Kabi
- Glatt
- Hovione
- Recipharm
- Siegfried
- CMIC Group
- Nectar Lifesciences
- Syngene
- WuXi AppTec
For more information about this report visit https://www.researchandmarkets.com/r/lmedyv
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
